October 29, 2021
Article
Growth, competition and equity were among the topics discussed at the Asembia’s 2021 Specialty Pharmacy Summit in Las Vegas this week
October 29, 2021
Article
3D printing of drugs at home. Simulated drug combinations. Treatments tailored to microbiomes. Deloitte’s George Van Antwerp spun some futuristic scenarios for pharmacy and healthcare at the Asembia specialty pharmacy meeting in Las Vegas.
October 29, 2021
Article
Risk Evaluation and Mitigation Strategies (REMS) programs are designed to protect patients, but they can also make providers more confident about prescribing a drug, explained panelists at the Asembia specialty pharmacy meeting. And the FDA collaborates with drugmakers on the planning the particulars of the programs, said Steve Granzyk and Tiffany Abraham.
October 28, 2021
Article
Because families and patients may experience many difficult — and confusing — years prior to a definitive diagnosis of a rare disease, specialty pharmacies need to do everything in their power to make the treatment as navigable as possible, advised Nick Calla, J.D., and Dave Frobel of Orsini Specialty Pharmacy.
October 28, 2021
Article
Members of a panel discussion on market access at Asembia’s specialty pharmacy meeting shared advise and insights into how best win acceptance and improve uptake of new products.
October 27, 2021
Article
Pharma industry experts Adam Fein, Ph.D., and Doug Long, MBA, described the growth of specialty pharmacy and the competition for that part of the pharma market during the opening presentation today at the Asembia 2021 Specialty Pharmacy Summit in Las Vegas.